Currently, the most promising candidate biomarkers for ALS are neurofilaments (NFs), particularly the neurofilament light chain (NfL) and the phosphorylated neurofilament heavy chain (pNfH), which are main components of the neuronal cytoskeleton.6 Here, NEFL is linked to amyotrophic lateral sclerosis.